• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
HealthBrainstorm Health

Brainstorm Health: Florida Medicaid Hack, Biotech Deals, Pfizer Ditches Alzheimer’s Research

By
Sy Mukherjee
Sy Mukherjee
Down Arrow Button Icon
By
Sy Mukherjee
Sy Mukherjee
Down Arrow Button Icon
January 8, 2018, 12:37 PM ET

Good morning, readers! This is Sy.

Florida officials revealed late Friday that a massive Medicaid hack may have exposed 30,000 patients’ sensitive personal information two months ago. The data breach, attributed to an employee who fell for a malicious “phishing” email in November, is just the latest example of a medical system infiltrated by cybercriminals—and you should expect to see even more health care data hacks in the coming years.

The fact that the Florida Medicaid breach, which may have allowed hackers to access Social Security numbers, patients’ names, addresses, medical information, birth dates, and other information, stemmed from a phishing scam is telling. User error is one of the simplest ways for cybercriminals to work their way into an organization’s IT infrastructure. And, given the sensitive nature of medical data, health care systems are a natural draw for cyberattacks.

The Federal Bureau of Investigation (FBI) has actually issued stark warnings to health care organizations over the threats of phishing emails and malware such as ransomware, which take data hostage in exchange for recompense. Ransomware is particularly prevalent in health care, as a 2017 Verizon Data Breach analysis reports. Between 2014 and 2017, ransomware surged from the the 22nd most common type of malware to the fifth most common. In fact, 72% of all health care malware attacks were ransomware. “For the attacker, holding files for ransom is fast, low risk and easily monetizable—especially with Bitcoin to collect anonymous payment,” wrote the Verizon report authors. The only industry more frequently targeted is financial services.

Some types of health care cyberattacks are more difficult to avoid than others, especially given the sorry state of health IT infrastructure. But one critical way to thwart would-be hackers is to follow common sense guidelines about passwords, suspicious emails, and other human behavior.

Sy Mukherjee
@the_sy_guy
sayak.mukherjee@fortune.com

DIGITAL HEALTH

Digital health upstart Amino launches HSA. Amino, a tech-savvy startup focused on tackling American health care's transparency problem, is launching a Health Savings Account (HSA) service within its platform. The startup says that HSAs are critical tools in an era of high deductible health plans, which require consumers to pay a higher share of their medical costs; however, the complicated and disparate nature of U.S. health care can make tools like HSAs difficult to understand and use (hence the integration into Amino's transparency-centric system).

INDICATIONS

JPMorgan Healthcare conference gets under way. It's that time of year again: The JPMorgan Healthcare conference and the Biotech Showcase in San Francisco, which attracts a who's who of the life sciences and investor crowd. Cliff is out attending the meeting, and we'll have you covered on the biggest developments out of JPM this week.

Pfizer to leave the Alzheimer's, Parkinson's spaces. Pfizer has decided to call it quits on developing new drugs for conditions like Alzheimer's and Parkinson's disease. Despite its heavy investments in these fields, it may not be much of a surprise that Pfizer is retrenching; Alzheimer's in particular is a notoriously difficult (and expensive) space. "This was an exercise to re-allocate spend across our portfolio, to focus on those areas where our pipeline, and our scientific expertise, is strongest," the company said in a statement. (Fortune)

Celgene strikes $7 billion deal for Impact. Speaking of JPMorgan—the conference often brings with it a flurry of deal-making news. And, as any biotech investor or analyst will tell you, the space is ripe for more aggressive M&A after a relatively subdued 2017. Drug maker Celgene became one of the first companies to announce a mid-size acquisition this year, snapping up Impact Biomedicines for up to $7 billion. In other news, Novo Nordisk issued a $3.1 billion bid for Ablynx, although the latter firm doesn't seem particularly eager for the deal. (Fortune)

THE BIG PICTURE

AMA: Physicians generated $2.3 trillion for the economy. The American Medical Association (AMA) is out with a new report defending the economic productivity of physicians in an attempt to ward off regulations in states that it considers burdensome to doctors and their abilities to practice. The eye-popping finding from the trade group? Physicians generated $2.3 trillion for the economy in 2015 and almost 12.6 million jobs. (Modern Healthcare)

REQUIRED READING

Sophia the Robot Is Learning to Walk, by Kirsten Korosec

These 100 Companies Are Leading the Way in AI, by Nicolas Rapp & Brian O'Keefe

What Apple Should Do About Kids Addicted to iPhones, by Adam Lashinsky

How Amazon, Netflix, and Hulu Fared At the Golden Globes, by Tom Huddleston Jr.

Produced by Sy Mukherjee
@the_sy_guy
sayak.mukherjee@fortune.com

Find past coverage. Sign up for other Fortune newsletters.
About the Author
By Sy Mukherjee
See full bioRight Arrow Button Icon

Latest in Health

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Lists Calendar
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Lists Calendar
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

Latest in Health

Hallucinogenics are illegal under federal law but that isn’t stopping the FDA from fast tracking 3 psychedelic drugs to treat mental health
PoliticsFDA
Hallucinogenics are illegal under federal law but that isn’t stopping the FDA from fast tracking 3 psychedelic drugs to treat mental health
By Matthew Perrone and The Associated PressApril 24, 2026
22 hours ago
smart glasses
AILondon
AI smart glasses are helping visually impaired runners take on the London Marathon
By The Associated Press and Mustakim HasnathApril 24, 2026
23 hours ago
Gainful Protein Review (2026): Expert Tested and Approved
HealthDietary Supplements
Gainful Protein Review (2026): Expert Tested and Approved
By Christina SnyderApril 24, 2026
24 hours ago
Exclusive: Michael Boes talks being named the first-ever chief MAHA officer. ‘Nothing’s been off the table’
C-SuiteHealth
Exclusive: Michael Boes talks being named the first-ever chief MAHA officer. ‘Nothing’s been off the table’
By Catherina GioinoApril 24, 2026
24 hours ago
The 5 Best Probiotics for IBS (2026): Expert reviewed and Approved
HealthDietary Supplements
The 5 Best Probiotics for IBS (2026): Expert reviewed and Approved
By Emily PharesApril 24, 2026
24 hours ago
suicide
Healthsuicide
Young adult suicide rate down 11% over 2.5 years of new 988 mental health crisis hotline
By Devi Shastri and The Associated PressApril 24, 2026
1 day ago

Most Popular

Despite nearing their 60s, nearly four in 10 Americans heading towards the end of their careers don’t even have a retirement account
Success
Despite nearing their 60s, nearly four in 10 Americans heading towards the end of their careers don’t even have a retirement account
By Emma BurleighApril 23, 2026
2 days ago
According to Warren Buffett's math the stock market is officially in 'playing with fire' territory. So when is the next crash coming?
Investing
According to Warren Buffett's math the stock market is officially in 'playing with fire' territory. So when is the next crash coming?
By Shawn TullyApril 25, 2026
11 hours ago
This is a ‘come to Jesus moment’: Ford CEO says American carmakers are battling a perfect storm
C-Suite
This is a ‘come to Jesus moment’: Ford CEO says American carmakers are battling a perfect storm
By Marco Quiroz-GutierrezApril 24, 2026
24 hours ago
This CEO lived on canned soup and took just two days off for his daughter’s birth. Now he admits he lost sight of proper work-life balance
Success
This CEO lived on canned soup and took just two days off for his daughter’s birth. Now he admits he lost sight of proper work-life balance
By Preston ForeApril 25, 2026
11 hours ago
When interest on national debt overtook military spending, it triggered a limit where the U.S. may ‘cease to be a great power,’ warns Hoover historian
Economy
When interest on national debt overtook military spending, it triggered a limit where the U.S. may ‘cease to be a great power,’ warns Hoover historian
By Eleanor PringleApril 23, 2026
2 days ago
The U.S. military may have already used up half of its most expensive missiles, and it could take up to 4 years to rebuild its stockpiles
Politics
The U.S. military may have already used up half of its most expensive missiles, and it could take up to 4 years to rebuild its stockpiles
By Sasha RogelbergApril 24, 2026
1 day ago

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.